Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, Stockerl-Goldstein K, Neumayer L, Langbaum TS, Theriault RL, Hughes ME, Weeks JC, Karp JE.

J Clin Oncol. 2015 Feb 1;33(4):340-8. doi: 10.1200/JCO.2013.54.6119. Epub 2014 Dec 22. Erratum in: J Clin Oncol. 2015 Apr 1;33(10):1227.

3.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

PMID:
17284714
4.

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.

Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA.

J Clin Oncol. 2004 Dec 1;22(23):4691-9. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570071
5.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
7.

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.

Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P.

JAMA Oncol. 2015 Oct;1(7):888-96. doi: 10.1001/jamaoncol.2015.2510.

PMID:
26291673
8.

Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.

Li S, Liu J, Virnig BA, Collins AJ.

Breast Cancer Res Treat. 2017 Feb;161(3):515-524. doi: 10.1007/s10549-016-4074-7. Epub 2016 Dec 8.

PMID:
27933451
9.

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ.

PLoS One. 2017 Sep 13;12(9):e0184747. doi: 10.1371/journal.pone.0184747. eCollection 2017.

10.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
11.

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.

Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP.

J Clin Oncol. 2010 Apr 20;28(12):2038-45. doi: 10.1200/JCO.2009.25.9796. Epub 2010 Mar 22.

12.

Mortality impact of less-than-standard therapy in older breast cancer patients.

Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA.

J Am Coll Surg. 2008 Jan;206(1):66-75. Epub 2007 Oct 3.

PMID:
18155570
13.

Neoadjuvant chemotherapy in stage III breast cancer.

Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.

Am Surg. 2005 Jun;71(6):487-92.

PMID:
16044927
14.

Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes.

Wright JL, Cordeiro PG, Ben-Porat L, Van Zee KJ, Hudis C, Beal K, McCormick B.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):43-50. Epub 2007 Sep 12.

PMID:
17855006
15.

Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.

Nagar H, Yan W, Christos P, Chao KSC, Nori D, Ravi A.

Am J Clin Oncol. 2017 Jun;40(3):300-305. doi: 10.1097/COC.0000000000000144.

PMID:
25333731
16.

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial.

Del Mastro L, De Placido S, Bruzzi P, De Laurentiis M, Boni C, Cavazzini G, Durando A, Turletti A, Nisticò C, Valle E, Garrone O, Puglisi F, Montemurro F, Barni S, Ardizzoni A, Gamucci T, Colantuoni G, Giuliano M, Gravina A, Papaldo P, Bighin C, Bisagni G, Forestieri V, Cognetti F; Gruppo Italiano Mammella (GIM) investigators.

Lancet. 2015 May 9;385(9980):1863-72. doi: 10.1016/S0140-6736(14)62048-1. Epub 2015 Mar 2.

PMID:
25740286
17.

Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.

Yao-Lung K, Dar-Ren C, Tsai-Wang C.

BMC Med Inform Decis Mak. 2012 Sep 17;12:108. doi: 10.1186/1472-6947-12-108.

18.

[Clinical analysis of resectable breast cancer: a report of 6 263 cases].

Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.

Ai Zheng. 2005 Mar;24(3):327-31. Chinese.

PMID:
15757535
19.

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.

Levy A, Borget I, Bahri M, Arnedos M, Rivin E, Vielh P, Balleyguier C, Rimareix F, Bourgier C.

Breast J. 2014 Jul-Aug;20(4):381-7. doi: 10.1111/tbj.12277. Epub 2014 Jun 2.

PMID:
24890310
20.

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.

Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E, Keane M, Gil M, Burkinshaw R, Grieve R, Barrett-Lee P, Ritchie D, Liversedge V, Hinsley S, Marshall H; AZURE investigators.

Lancet Oncol. 2014 Aug;15(9):997-1006. doi: 10.1016/S1470-2045(14)70302-X. Epub 2014 Jul 15.

PMID:
25035292

Supplemental Content

Support Center